Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

Figure 1

Kaplan-Meyer plots of EFS of stage 4 patients stratified according to the level of mRNA expression below (continuous line) or above (dotted line) the median of CD45 (a), CD14 (b), CD163 (c), ARG1 (d), CD4 (e), FOXP3 (f), PRF1 (g), GZMB (h), and IL10 (i).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)